218 related articles for article (PubMed ID: 24205164)
1. Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.
Zhao X; Zhai S; An MS; Wang YH; Yang YF; Ge HQ; Liu JH; Pu XP
PLoS One; 2013; 8(10):e78220. PubMed ID: 24205164
[TBL] [Abstract][Full Text] [Related]
2. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
[TBL] [Abstract][Full Text] [Related]
4. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both
Guo C; Zhu J; Wang J; Duan J; Ma S; Yin Y; Quan W; Zhang W; Guan Y; Ding Y; Wen A; Zhang Y
Aging (Albany NY); 2019 Nov; 11(21):9424-9441. PubMed ID: 31697645
[TBL] [Abstract][Full Text] [Related]
6. DJ-1-Mediated protective effect of protocatechuic aldehyde against oxidative stress in SH-SY5Y cells.
Gao JW; Yamane T; Maita H; Ishikawa S; Iguchi-Ariga SM; Pu XP; Ariga H
J Pharmacol Sci; 2011; 115(1):36-44. PubMed ID: 21160133
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease.
Liu Q; Sang Heon K; Yung-Wei S; Sok Cheon P; Wonwoong L; Jongki H; Jaehwan J; Kyoung Sang C; Songhee J; Byung-Soo K
J Tradit Chin Med; 2019 Dec; 39(6):800-808. PubMed ID: 32186150
[TBL] [Abstract][Full Text] [Related]
9. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats.
Sun SY; An CN; Pu XP
Brain Res Bull; 2012 Sep; 88(6):609-16. PubMed ID: 22664331
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
12. Triple herbal extract DA-9805 exerts a neuroprotective effect via amelioration of mitochondrial damage in experimental models of Parkinson's disease.
Jeong JS; Piao Y; Kang S; Son M; Kang YC; Du XF; Ryu J; Cho YW; Jiang HH; Oh MS; Hong SP; Oh YJ; Pak YK
Sci Rep; 2018 Oct; 8(1):15953. PubMed ID: 30374025
[TBL] [Abstract][Full Text] [Related]
13. Transduced Tat-DJ-1 protein protects against oxidative stress-induced SH-SY5Y cell death and Parkinson disease in a mouse model.
Jeong HJ; Kim DW; Woo SJ; Kim HR; Kim SM; Jo HS; Park M; Kim DS; Kwon OS; Hwang IK; Han KH; Park J; Eum WS; Choi SY
Mol Cells; 2012 May; 33(5):471-8. PubMed ID: 22526393
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease.
Kim HG; Ju MS; Kim DH; Hong J; Cho SH; Cho KH; Park W; Lee EH; Kim SY; Oh MS
Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):958-64. PubMed ID: 20629656
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
Qi X; Davis B; Chiang YH; Filichia E; Barnett A; Greig NH; Hoffer B; Luo Y
J Neurochem; 2016 Sep; 138(5):746-57. PubMed ID: 27317935
[TBL] [Abstract][Full Text] [Related]
17. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
Kim HD; Jeong KH; Jung UJ; Kim SR
J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
[TBL] [Abstract][Full Text] [Related]
18. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
[TBL] [Abstract][Full Text] [Related]
19. STAT3 protects dopaminergic neurons against degeneration in animal model of Parkinson's disease.
Smit RD; Ghosh B; Campion TJ; Stingel R; Lavell E; Hooper R; Fan X; Soboloff J; Smith GM
Brain Res; 2024 Feb; 1824():148691. PubMed ID: 38030102
[TBL] [Abstract][Full Text] [Related]
20. 4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson's Disease.
Shi L; Jia L; Wang Y; Xiu M; Xie J
Neurochem Res; 2023 Jun; 48(6):1707-1715. PubMed ID: 36602724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
